Alpha-aminoamide Derivative Compound And Pharmaceutical Composition Containing The Same

  • Published: Aug 9, 2017
  • Earliest Priority: Oct 02 2014
  • Family: 14
  • Cited Works: 0
  • Cited by: 0
  • Cites: 0
  • Additional Info:

The full document isn't yet available to us from the patent office.


The present disclosure relates to an ±-aminoamide derivative compound and a pharmaceutical composition containing the same. According to various embodiments of the present disclosure, provided is a therapeutic agent which can overcome the disadvantages of existing drugs used as a MAO-B inhibitor and, specifically, reversibly inhibits MAO-B through a non-covalent bond so as to alleviate or eliminate the side effects of the existing drugs which exhibit a therapeutic effect by irreversibly acting via a covalent bond with MAO-B. Particularly, a new compound having superior stability and efficacy compared to the existing reversible MAO-B inhibitors may be provided.


Information currently unavailable.

Download PDF
Document Preview
Document History
  • Publication: Aug 9, 2017
  • Application: Sep 24, 2015
    EP EP 15847985 A
  • Priority: Sep 24, 2015
    KR KR 2015010104 W
  • Priority: Sep 18, 2015
    KR KR 20150132281 A
  • Priority: Oct 2, 2014
    KR KR 20140132983 A

Download Citation

Sign in to the Lens